IGM BIOSCIENCES INC's ticker is IGMS and the CUSIP is 449585108. A total of 80 filers reported holding IGM BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $156,102 | -18.9% | 18,696 | -10.3% | 0.00% | – |
| Q2 2023 | $192,445 | +93775.6% | 20,850 | +39.6% | 0.00% | – |
| Q1 2023 | $205 | -18.3% | 14,935 | +1.4% | 0.00% | – |
| Q4 2022 | $251 | -99.9% | 14,731 | +3.4% | 0.00% | – |
| Q3 2022 | $324,000 | +39.7% | 14,240 | +10.5% | 0.00% | – |
| Q2 2022 | $232,000 | -6.1% | 12,883 | +39.7% | 0.00% | – |
| Q1 2022 | $247,000 | +6.5% | 9,222 | +16.5% | 0.00% | – |
| Q4 2021 | $232,000 | -56.2% | 7,914 | -1.8% | 0.00% | -100.0% |
| Q3 2021 | $530,000 | -17.2% | 8,056 | +4.7% | 0.00% | 0.0% |
| Q2 2021 | $640,000 | +9.0% | 7,695 | +0.5% | 0.00% | 0.0% |
| Q1 2021 | $587,000 | -16.6% | 7,655 | -4.0% | 0.00% | 0.0% |
| Q4 2020 | $704,000 | +26.4% | 7,971 | +5.6% | 0.00% | 0.0% |
| Q3 2020 | $557,000 | -13.4% | 7,551 | -14.3% | 0.00% | 0.0% |
| Q2 2020 | $643,000 | +132.1% | 8,811 | +78.7% | 0.00% | 0.0% |
| Q1 2020 | $277,000 | – | 4,930 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,334,355 | $75,823,000 | 2.94% |
| Artal Group S.A. | 2,450,000 | $55,713,000 | 2.38% |
| Samsara BioCapital, LLC | 154,664 | $3,517,000 | 0.82% |
| Eagle Bay Advisors LLC | 41,635 | $947,000 | 0.58% |
| Baker Brothers Advisors | 3,156,102 | $71,770,000 | 0.47% |
| Bruce & Co., Inc. | 55,000 | $1,250,000 | 0.34% |
| Corton Capital Inc. | 9,999 | $227,000 | 0.28% |
| Delphia (USA) Inc. | 10,185 | $232,000 | 0.26% |
| Alkeon Capital Management | 961,613 | $21,867,000 | 0.07% |
| Virtus ETF Advisers LLC | 7,319 | $166,000 | 0.07% |